[A disease accessible to treatment].

N. Roche

DOI: https://doi.org/10.1016/S0755-4982(04)98497-7

2004-01-31

Presse Medicale

Abstract:

What problem does this paper attempt to address?

Preferential Maternal Transmission of STX16-GNAS Mutations Responsible for Autosomal Dominant Pseudohypoparathyroidism Type Ib (PHP1B): Another Example of Transmission Ratio Distortion

Zentaro Kiuchi,Monica Reyes,Harald Jüppner

DOI: https://doi.org/10.1002/jbmr.4221

Abstract:Preferential transmission of a genetic mutation to the next generation, referred to as transmission ratio distortion (TRD), is well established for several dominant disorders, but underlying mechanisms remain undefined. Recently, TRD was reported for patients affected by pseudohypoparathyroidism type Ia or pseudopseudohypoparathyroidism. To determine whether TRD is observed also for autosomal dominant pseudohypoparathyroidism type Ib (AD-PHP1B), we analyzed kindreds with the frequent 3-kb STX16 deletion or other STX16/GNAS mutations. If inherited from a female, these genetic defects lead to loss-of-methylation at exon A/B alone or at all three differentially methylated regions (DMR), resulting in parathyroid hormone (PTH)-resistant hypocalcemia and hyperphosphatemia and possibly resistance to other hormones. In total, we investigated 212 children born to 80 females who are unaffected carriers of a STX16/GNAS mutation (n = 47) or affected by PHP1B (n = 33). Of these offspring, 134 (63.2%) had inherited the genetic defect (p = .00012). TRD was indistinguishable for mothers with a STX16/GNAS mutation on their paternal (unaffected carriers) or maternal allele (affected). The mechanisms favoring transmission of the mutant allele remain undefined but are likely to include abnormalities in oocyte maturation. Search for mutations in available descendants of males revealed marginally significant evidence for TRD (p = .038), but these analyses are less reliable because many more offspring of males than females with a STX16/GNAS mutation were lost to follow-up (31 of 98 versus 6 of 218). This difference in follow-up is probably related to the fact that inheritance of a mutation from a male does not have clinical implications, whereas inheritance from an affected or unaffected female results in PHP1B. Lastly, affected PHP1B females had fewer descendants than unaffected carriers, but it remains unclear whether abnormal oocyte development or impaired actions of reproductive hormones are responsible. Our findings highlight previously not recognized aspects of AD-PHP1B that are likely to have implications for genetic testing and counseling. © 2020 American Society for Bone and Mineral Research (ASBMR).
[Pseudohypoparathyroidism and GNAS Gene Defects: Clinical Evaluation and Molecular Analysis in 20 Children].

X Q Xu,X L Zhou,X F Chen,J N Yuan,Y L Dai,K Huang,G P Dong,W Wu,J F Fu

DOI: https://doi.org/10.3760/cma.j.cn112140-20201110-01018

2021-01-01

Abstract:Objective: To analyze the patients' clinical and genetic characteristics with pseudohypoparathyroidism (PHP) and investigate the correlation between clinical phenotypes and genotypes. Methods: Twenty PHP patients were ascertained at Children's Hospital Zhejiang University School of Medicine from January 2011 to July 2020. Clinical manifestation, laboratory examination and gene test results were retrospectively analyzed. Results: In these twenty patients, eighteen cases showed resistance to parathyroid hormone (PTH) and thirteen cases had Albright's hereditary osteodystrophy (AHO) phenotype. Gene abnormalities were found in all the twenty PHP patients, which included seven patients with GNAS gene variations (six frameshifts and one missense) and thirteen patients with GNAS gene methylation defects. Moreover, twelve children with both PTH resistance and AHO phenotype were clinically diagnosed as PHP-Ⅰa, meanwhile, seven carried GNAS variations and five had methylation abnormalities with a correct diagnosis of PHP-Ⅰb. Conclusions: Patients with AHO phenotype and PTH resistance may have a high genetic diagnosis rate. Because PHP-Ⅰb clinical phenotype may be similar to PHP-Ⅰa, early genetic detection is required for the differential diagnosis. In addition, children without PTH resistance should also be followed up regularly, which may help the early diagnosis.
Lifelong Deformities in an Adult Caused by Vitamin D‑dependent Rickets Type 1A: A Case Report

Caihong Yi,Juan Xu,Jiangping He,Xiaofang Zhang,Xianfeng Zhang,Jiao Huang

DOI: https://doi.org/10.3892/etm.2022.11698

IF: 2.7

2022-01-01

Experimental and Therapeutic Medicine

Abstract:Vitamin D-dependent rickets (VDDR) type 1A is a rare autosomal recessive disorder caused by cytochrome P450 family 27 subfamily B member 1 (CYP27B1) mutations and can lead to deficiencies in 1α-hydroxylase activity. The present study describes the case of a 39-year-old male patient who presented with rickets and deformities of limbs. Blood biochemical analysis revealed hypocalcemia and high serum parathyroid hormone (PTH) levels. Whole-exome Sanger sequencing using peripheral venous blood of this patient and his parents revealed exon1 c.182T>C, a novel mutation. Through physical examination, laboratory tests, imaging including lower limbs and lumbar spine X-ray and pelvis CT scan, and genetic testing, the patient was diagnosed with VDDR-1A. Following 1 month of treatment with 0.5 µg 1,25-dihydroxy-vitamin D3 twice daily and 0.6 g calcium carbonate once daily, follow-up examinations revealed that the patient's PTH and serum calcium levels had returned to normal. As the patient was diagnosed in his adulthood and missed the optimal treatment period, he developed irreversible deformities. If VDDR-1A can be diagnosed during infancy and childhood, skeletal deformities may be prevented. Therefore, the present report supports the proposal of early genetic sequencing in children with calcium deficiencies for the early diagnosis of rare diseases such as VDDR-1A, -1B and -2A and hereditary hypophosphatemic rickets. Since VDDR-1A diagnosed in adults is rare, the present case may provide clinicians with further insights into the characteristics of this rare disease.
STX16 exon 5–7 deletion in a patient with pseudohypoparathyroidism type 1B

Li Chen,Chuanbin Yang,Xiaoxiao Zhang,Beibei Chen,Peibing Zheng,Tingting Li,Wenjing Song,Hua Gao,Xiaofang Yue,Jiajun Yang

DOI: https://doi.org/10.1515/jpem-2023-0562

2024-07-20

Journal of Pediatric Endocrinology and Metabolism

Abstract:Pseudohypoparathyroidism (PHP) comprises a cluster of heterogeneous diseases characterized by hypocalcemia and hyperphosphatemia due to parathyroid hormone (PTH) resistance. PHP type 1B (PHP1B) is caused by heterozygous maternal deletions within GNAS or STX16. STX16 exon 2–6 deletion is commonly observed in autosomal dominant (AD)-PHP1B, while sporadic PHP1B commonly results from methylation abnormalities of maternal differentially methylated regions and remains unclear at the molecular level. A 39-year-old male patient with PHP1B, who had his first seizure at 15 years of age, presented to our hospital. The methylation-specific multiplex ligation-dependent probe amplification results showed a half-reduced copy number of STX16 exon 5–7 and loss of methylation at GNAS exon A/B. His mother also had a half-reduced copy number of STX16 exon 5–7 but with normal methylation of GNAS. His father has a normal copy number of STX16 and normal methylation of GNAS. For the recognition and early diagnosis of this kind of disease, here we report the clinical symptoms, auxiliary examinations, genetic testing characteristics, and treatment of the patient.

pediatrics,endocrinology & metabolism
Identification of a Novel Mutation in Pseudohypoparathyroidism Type Ia in a Chinese Family

Yuchen Tang,Fenping Zheng,Xihua Lin,Qianqian Pan,Lin Li,Hong Li

DOI: https://doi.org/10.1097/md.0000000000019965

IF: 1.6

2020-01-01

Medicine

Abstract:Introduction: Pseudohypoparathyroidism (PHP) indicates a group of rare disorders characterized by end-organ resistance to various hormones, primarily parathyroid hormone (PTH). One of its most common type is PHP-Ia, which is caused by maternally inherited inactivating mutations inGNAS.In this report, we present a Chinese girl with typical features of PHP-Ia and a novel mutation of theGNASgene. Patient concerns: A 9-year-old Chinese girl presented with recurrent epileptic seizure. Diagnosis: Biochemical and imaging findings were consistent with PHP-Ia, including typical Albright hereditary osteodystrophy phenotype (short stature, round face, brachydactyly, and mild mental retardation), PTH resistance (hypocalcemia, hyperphosphatemia, elevated serum PTH, and multiple intracranial calcification) and thyroid stimulating hormone resistance (elevated serum thyroid stimulating hormone). Interventions: The patient was given 1 alpha-hydroxylated vitamin D (calcitriol, 0.5 ug/d), calcium carbonate and vitamin D(3)tablets (1.5 g/d, including 600 mg calcium and 125 IU vitamin D-3). DNA analysis of theGNASgene was performed for the whole family. Outcomes: Investigation of theGNASgene revealed a novel mutation c.313delG (p.Glu105Lysfs*7) in the patient, as well as her mother. So the diagnosis of PHP-Ia was confirmed. Conclusion: The study further expands the spectrum of knownGNASmutations associated with PHP and lay emphasis on the genetic analysis ofGNASgene for identifying genetic abnormalities as well as making diagnosis and differentiation of various subtypes of PHP.
The proximal-distal continuum of multiple health outcome measures: the case of cataract surgery.

M. Brenner,Barbara Curbow,M. Legro

1995-04-01

Medical Care

Abstract:This paper presents the concept of a proximal-distal continuum in health outcome measures. It indicates how this continuum can be used in the selection of outcome measures in health technology evaluation studies. Finally, it demonstrates several ways in which the placement of a specific health outcome measure in the proximal-distal continuum determines the overall statistical model of treatment and nontreatment variables. We identify five principles that relate to the above issues. The first three principles state that a larger effect of treatment on health outcomes will be seen when the following occur: 1) more proximal (e.g., signs and symptoms, disease-specific outcomes) measures are examined, 2) the initial illness is more severe; and 3) pretreatment distal (e.g., role functioning, life satisfaction) outcome measures show relatively high impairment. Principle four indicates that distal outcomes are influenced more heavily by external (i.e., nontreatment) factors. Principle five states that a causal chain links each outcome measure in the continuum to the next more distal outcome measure. This last principle enables the determination of indirect relationships between treatment and outcomes. These principles are illustrated with data from a study on the effects of cataract surgery with intraocular lens implantation on patient outcome variables across the proximal-distal continuum.
WDM-PON Architecture with C-band OLT, L-band ONU, and U-band Monitoring Based on FP-LDs wavelength-locked by a Single, Depolarized, CW Supercontinuum

J. Lee,Young-Geun Han,Sang Bae Lee

DOI: https://doi.org/10.1109/OFC.2007.4348792

2007-03-25

Abstract:We experimentally demonstrate a novel bidirectional WDM-PON architecture based on a single, depolarized, 130 ran, CW supercontinuum source. The architecture incorporating low- cost, wavelength-locked FP-LDs features a unique wavelength band allocation scheme of the C- band for an OLT, the L-band for ONUs, and the U-band for channel monitoring.
A diagnostic test for scrapie‐infected sheep using a capillary electrophoresis immunoassay with fluorescent‐labeled peptides

M. J. Schmerr,A. Jenny

DOI: https://doi.org/10.1002/elps.1150190308

1998-03-01

Electrophoresis

Abstract:Scrapie in sheep and goats is the prototype of transmissible spongiform encephalopathies found in humans and animals. A feature of these diseases is the accumulation of rod‐shaped fibrils in the brain that form from an aggregated protein. This protein (PrPSC) is a protease‐resistant form of a normal host cell protein. When the aggregated protein is denatured in sodium dodecyl sulfate (SDS) and β‐mercaptoethanol, a monomer form of ∼27 kDa molecular mass is observed. A competition immunoassay to detect PrPSC from scrapie‐infected sheep was developed using free zone capillary electrophoresis with laser‐induced fluorescence (LIF) for detection and flourecein‐labeled sysnthetic peptides from PrPSC. Antibodies were made to each respective peptide and used in the competition assay. The fluorescent‐labeled peptides bound to the antibody were separated from the unbound peptides using 200 mM Tricine, pH 8.0, containing 0.1% n‐octylglucoside and 0.1% bovine serum albumin (BSA). The amount of antibody that would bind ∼50% of the fluorescent‐labeled peptide was determined for each peptide. When unlabeled peptide was added to the assay, ∼2 fmoles of the peptide could be measured. When PrPSC extracted from infected sheep brain was added to the assay, approximately 135 pg of PrPSC could be detected. When preparations from normal sheep were assayed, there was little or no competition for the bound peptides. Assays using two of the peptides, peptides spanning amino acid positions 142–154 and 155–178, clearly differentiated scrapie‐positive sheep from normal animals. This assay is a new method that can be used to diagnose scrapie and, possibly, other transmissible spongiform encephalopathies in animals and in humans.
Diagnosis and approach of pseudohypoparathyroidism type 1A and related disorders during long term follow-up: a case report

Mónica Expósito Raspeño,Verónica Sánchez Escudero,Guiomar Pérez de Nanclares Leal,María Ortiz Santamaría,Rosa Sánchez-Dehesa Sáez,Beatriz García Cuartero,Amparo González Vergaz

DOI: https://doi.org/10.1515/jpem-2023-0454

2024-02-15

Journal of Pediatric Endocrinology and Metabolism

Abstract:Objectives Pseudohypoparathyroidism type 1A (PHP1A) encompasses the association of resistance to multiple hormones, features of Albright hereditary osteodystrophy and decreased Gsα activity. Little is known about the early signs of PHP1A, with a delay in diagnosis. We report two PHP1A cases and their clinical and biochemical findings during a 20-year follow-up. Case presentation Clinical suspicion was based on obesity, TSH resistance and ectopic ossifications which appeared several months before PTH resistance, at almost 3 years of age. Treatment with levothyroxine, calcitriol and calcium was required in both patients. DNA sequencing of GNAS gene detected a heterozygous pathogenic variant within exon 7 (c.569_570delAT) in patient one and a deletion from XLAS to GNAS-exon 5 on the maternal allele in patient 2. In patient 1, ectopic ossifications that required surgical excision were found. Noticeably, patient 2 displayed adult short stature, intracranial calcifications and psychomotor delay. In terms of weight, despite early diagnosis of obesity, dietary measures were established successfully in both cases. Conclusions GNAS mutations should be considered in patients with obesity, ectopic ossifications and TSH resistance presented in early infancy. These cases emphasize the highly heterogeneous clinical picture PHP1A patients may present, especially in terms of final height and cognitive impairment.

pediatrics,endocrinology & metabolism
Clinical and genetic analysis of pseudohypoparathyroidism complicated by hypokalemia: a case report and review of the literature

Shaohan Huang,Yingzi He,Xihua Lin,Shuiya Sun,Fenping Zheng

DOI: https://doi.org/10.1186/s12902-022-01011-9

2022-01-01

BMC Endocrine Disorders

Abstract:Background Pseudohypoparathyroidism (PHP) encompasses a highly heterogenous group of disorders, characterized by parathyroid hormone (PTH) resistance caused by mutations in the GNAS gene or other upstream targets. Here, we investigate the characteristics of a female patient diagnosed with PHP complicated with hypokalemia, and her family members. Case presentation and gene analysis A 27-year-old female patient occasionally exhibited asymptomatic hypocalcemia and hypokalemia during her pregnancy 1 year ago. Seven months after delivery, she experienced tetany and dysphonia with diarrhea. Tetany symptoms were relieved after intravenous calcium gluconate supplementation and she was then transferred to our Hospital. Laboratory assessments of the patient revealed hypokalemia, hypocalcemia and hyperphosphatemia despite elevated PTH levels. CT scanning of the brain revealed globus pallidus calcification. Possible mutations in GNAS and hypokalemia related genes were identified using WES, exon copies of STX16 were analized by MLPA and the methylation status of GNAS in three differential methylated regions (DMRs) was analyzed by methylation-specific polymerase chain reaction, followed by confirmation with gene sequencing. The patient was clinically diagnosed with PHP-1b. Loss of methylation in the A/B region and hypermethylation in the NESP55 region were detected. No other mutations in GNAS or hypokalemia related genes and no deletions of STX16 exons were detected. A negative family history and abnormal DMRs in GNAS led to a diagnosis of sporadic PHP-1b of the patient. Conclusions Hypokalemia is a rare disorder associated with PHP-1b. Analysis of genetic and epigenetic mutations can aid in the diagnosis and accurate subtyping of PHP.
One Patient with Perinatal Hypophosphatasia Due to Mutations in the Tissue-Nonspecific Alkaline Phosphatase Gene

余颖芳,陈安,郑季彦,陈理华,杜立中

DOI: https://doi.org/10.3760/cma.j.cn311282-20190313-00088

2020-01-01

Abstract:Objective:To explore the clinical and genetic characteristics of a Chinese baby with perinatal hypophosphatasia (HPP) and his parents for better understanding of the disease.Methods:The clinical data of the patient with HPP was carefully collected. The laboratory and radiographic examination data were taken for this baby patient. Sequencing for all the twelve tissue-nonspecific alkaline phosphatase(ALPL) exons and the flanking exon-intron junctions were performed in the proband and his parents with their genomic DNA from peripheral blood.Results:The blood level of alkaline phosphatase was decreased in this patient while serum calcium level was increased. His bone revealed chondrodysplasia-like change. Compound heterozygous mutations were found in the proband, with c. 346G>A(p.A116T) in exon 5 and c. 1171C>T(p.R391C) in exon 10. His father and mother were without clinical manifestation while respectively carried c. 346G>A(p.A116T and c. 1171C>T(p.R391C) missense mutations, suggesting an autosomal recessive inheritance in this family.Conclusion:Perinatal HPP has a high mortality rate. Skeletal deformities, hypercalcemia, and low level of ALP are important in the differential diagnosis of perinatal HPP.
Clinical and Genetic Characteristics of Hypoparathyroidism in Children: a Multicenter Experience in China

Yingxiao Shen,Wei Yang,Qin He,Xiaoqin Xu,Yan Sun,Zhihua Wang,Xiaohong Yang,Guanping Dong,Ke Huang,Haiyan Wei,Wei Wu,Junfen Fu

DOI: https://doi.org/10.1007/s40618-024-02465-5

2024-01-01

Journal of Endocrinological Investigation

Abstract:This study was aimed to analyze the clinical and genetic characteristics of hypoparathyroidism in children. We performed a retrospective analysis of 74 patients diagnosed with pediatric hypoparathyroidism from 2014 to 2023, recruited in five medical centers across China. Data of basic information and clinical tests were extracted from patients’ records. Whole-exome sequencing (WES), multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray analysis (CMA) were utilized to identify the genetic causes. The results indicated a median onset age of 6.07 ± 4.82 years and a median diagnosis age of 6.91 ± 4.88 years. Of the 46 patients who underwent genetic tests, 35 were found to carry pathogenic variants related to hypoparathyroidism. Specifically, 19 cases (19/46, 41.30
Pseudohypoparathyroidism Type IB with Subclinical Hypothyroidism: a Pedigree Investigation and Literature Review

DOI: https://doi.org/10.2147/dmso.s458405

2024-05-14

Diabetes Metabolic Syndrome and Obesity Targets and Therapy

Abstract:Jie Liu, Lijuan Lu, Yu Wei, Yu Li, Qiong Wang, Lei Yu, Langen Zhuang, Guoxi Jin, Xiaoyan Pei Department of Endocrinology, the First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui Province, People's Republic of China Correspondence: Guoxi Jin; Xiaoyan Pei, Department of Endocrinology, the First Affiliated Hospital of Bengbu Medical University, No. 287 Changhuai Road, Bengbu, Anhui Province, 233000, People's Republic of China, Email ; Pseudohypoparathyroidism (PHP) is a rare genetic disease characterized by hypocalcemia, hyperphosphatemia, and elevated parathyroid hormone (PTH) in serum. Here, we report a case of a patient with pseudohypoparathyroidism type IB (PHPIB) and subclinical hypothyroidism, analyze the clinical and genetic data of his family members, review the relevant literature, and classify and discuss the pathogenesis and clinical characteristics of each subtype. Finally, we discuss the treatment approach to improve clinicians' understanding of the disease. Keywords: hypocalcemia, parathyroid hormone resistance, GNAS, STX16, molecular genetic mechanism Pseudohypoparathyroidism (PHP) is a rare hereditary endocrine disease with high heterogeneity. The molecular genetic mechanism of PHP is related to an inactivation mutation or an epigenetic modification of the GNAS gene, which encodes stimulating G protein α subunit (Gsα). 1 The change in the GNAS gene leads to a decrease in Gsα activity, so it cannot activate the downstream adenylate cyclase system to produce the second messenger cyclic adenosine monophosphate (cAMP). Finally, the inhibition of the Gsα/cAMP/protein kinase A (PKA) signaling pathway produces a series of pathological reactions. 2 The first symptoms are usually those of tetany due to low calcium, and some patients have epileptic seizures. In other cases, the first symptoms are skin heterotopic ossification, congenital hypothyroidism, or dwarfism. The main feature of the disease is the resistance of target organs (bone and kidney) to parathyroid hormone (PTH), which results in hypocalcemia, hyperphosphatemia, and elevated serum PTH concentration. Other clinical manifestations include ectopic calcification (especially in the basal ganglia and lens), ectopic ossification (most often in the dermis and subcutaneous fat), and Albright hereditary osteodystrophy (AHO). In some cases, resistance to other hormones such as thyroid-stimulating hormone (TSH), growth hormone–releasing hormone (GHRH), and follicle-stimulating hormone (FSH)/luteinizing hormone (LH) may also occur. 3,4 A 32-year-old woman was admitted to the neurology outpatient clinic of our hospital for "dizziness and headache for 2 weeks." She did not experience nausea and vomiting. Head computed tomography (CT) showed bilateral symmetrical high-density shadows in the basal ganglia that resembled those in metabolic lesions (Figure 1). The concentrations of biochemical parameters were as follows: total calcium, 2.18 (normal range, 2.11–2.52) mmol/L; inorganic phosphorus, 1.40 (normal range, 0.85–1.51) mmol/L; PTH, 231 (normal range, 12–88) pg/mL. She was then transferred to the endocrinology outpatient clinic and admitted to the hospital. Her medical history revealed that she had seen a doctor in another hospital 4 years ago because of facial and limb convulsions. At that time, the following parameters were measured: calcium, 1.43 (2.11–2.52) mmol/L; PTH, 439.70 (12–88) pg/mL; thyroxine, 84.70 (55.34–160.88) nmol/L; TSH, 5.96 (0.40–4.34) mIU/L; on that basis, the patient was diagnosed with "hypocalcemia" and "subclinical hypothyroidism." She was discharged with symptomatic treatment, including supplementation of calcium, vitamin D, and thyroid hormone. She usually took calcium tablets (details unknown) and did not undergo follow-up examinations. She denied any history of chronic disease and surgery but reported that her brother had a history of hypocalcemia. There was no genetic history in the family. Physical examination revealed the following: blood pressure, 100/75 mm Hg; height, 160 cm; weight, 55.5 kg; BMI, 21.7 kg/m2; clear mind, normal development, good nutrition; no abnormalities of the heart, lungs, and abdomen; no obvious abnormalities of the spine and limbs; Chvostek sign, Trousseau sign, and peroneal nerve reflex were all negative. Figure 1 Head CT. Related examination on the first day of hospitalization: total calcium, 1.96 (2.11–2.52) mmol/L; ionized calcium 1.05 (1.10–1.34) mmol/L; inorganic phosphorus 1.25 (0.85–1.51) mmol/L; 25-hydroxyvitamin D, 19.91 (>20) ng/mL; urinary calcium, 2.91 (2.50–7.50) mmol/L; urinary phosphorus, 7.44 (32.3–38.4) mmol/L; free thyroxine 17.53 (10.43–24.32) pmol/L; TSH, 6.31 (0.40–4.34) mIU/L. There were no obvious abnormalities in blood routine, urine routine, liver and kidney function parameters, bicarbonate, se -Abstract Truncated-

endocrinology & metabolism
Growth Hormone Deficiency in an Adolescent With Pseudohypoparathyroidism Type 1B

Sabitha Sasidharan Pillai,Monica Reyes,Harald Jüppner,Lisa Swartz Topor

DOI: https://doi.org/10.1210/jcemcr/luae152

2024-08-27

Abstract:We report growth hormone (GH) deficiency due to presumed GH releasing hormone (GHRH) resistance in an adolescent with pseudohypoparathyroidism type 1B (PHP1B) due to paternal uniparental disomy of chromosome 20 (patUPD20). A male patient aged 11 years 10 months with obesity and mild developmental delay was found to have hypocalcemia, hyperphosphatemia, and an elevated parathyroid hormone level. History included muscle cramps and leg pain with activity. Examination showed round facies, short stature, and obesity. He was in puberty and bone age was advanced by > 2 years. Detailed genetic workup, including nucleotide sequence analysis of GNAS exons 1-13 and STX16, methylation-sensitive multiplex ligation-dependent probe amplification and analysis of several microsatellite markers for chromosome 20, established the diagnosis of PHP1B due to patUPD20. Muscle cramps and hypocalcemia resolved with calcium carbonate, ergocalciferol, and calcitriol treatment. He was short with linear growth deceleration at around age 13 years. Peak GH concentration was insufficient following stimulation testing. Growth velocity improved with human GH treatment. Although rare, resistance to GHRH can occur in PHP1B and patients with this disorder should be evaluated for GH insufficiency if they present with short stature and reduced growth velocity. Treatment with recombinant human GH may improve growth velocity in such patients.
High Prevalence of Hypercalcitoninemia in a Large Cohort of Adult and Pediatric Patients With PTH Resistance Syndromes

Arianna Cremaschi,Giulia Del Sindaco,Angela Pagnano,Alessia Dolci,Jugurtha Berkenou,Anya Rothenbuhler,Andrea Contarino,Emanuele Ferrante,Maura Arosio,Elisa Giannetta,Agnès Linglart,Giovanna Mantovani

DOI: https://doi.org/10.1210/clinem/dgae416

2024-06-28

The Journal of Clinical Endocrinology & Metabolism

Abstract:Abstract Context Pseudohypoparathyroidism (PHP) refers to a group of rare hereditary disorders associated with resistance to parathyroid hormone (PTH) and other hormones now termed inactivating PTH/PTHrP disorders (iPPSD). Hypercalcitoninemia has been seldom reported in small series. Objective Our aim was to investigate the characteristics of hypercalcitoninemia in pediatric and adult patients with PHP/iPPSD. Methods We retrospectively collected data from 2 cohorts from 2 European endocrinology tertiary centers: the pediatric cohort comprised 88 children with available calcitonin (CT) measurements; the adult cohort included 43 individuals with simultaneous CT and PTH measurements. Results In the pediatric cohort, 65.9% had hypercalcitoninemia (median CT 15 ng/L); in the adult cohort 53.5% (mean CT 21.6 ng/L). There was no difference between CT in pediatric and adult population; we observed stable CT levels over a median follow-up of 134.5 months in adults. Notably, no correlations were detected between CT and PTH levels. Other etiologies of hypercalcitoninemia were excluded; adult patients underwent regular thyroid ultrasound to screen for medullary thyroid cancer (MTC). We performed 20 calcium stimulation tests in adult patients. While there was a significant difference in basal and peak CT between our patients, healthy subjects, and subjects with MTC, there was no difference with patients with C-cell hyperplasia. Conclusion This study underscores the common occurrence of hypercalcitoninemia in both pediatric and adult patients with PHP/iPPSD, in particular with subtypes iPPSD2 and iPPSD3. Furthermore, these patients show hyperresponsiveness to calcium stimulation tests falling between healthy subjects and patients with MTC. These findings contribute to the understanding of CT dynamics in the context of PHP/iPPSD.

endocrinology & metabolism
A novel GNAS mutation in pseudohypoparathyroidism type 1a with articular flexion deformity: A case report

Jinxing Wan,Dongjuan He,Jun Xie,Zhizhi Chen

DOI: https://doi.org/10.1515/biol-2022-0918

2024-07-25

Open Life Sciences

Abstract:Pseudohypoparathyroidism (PHP) type 1a (PHP 1a) is a rare hereditary disorder characterized by target organ resistance to hormonal signaling and the Albright hereditary osteodystrophy (AHO) phenotype, which features round facial features, short fingers, subcutaneous calcifications, short stature, obesity, and intellectual disability. Progressive osseous heteroplasia (POH) is another rare disorder characterized by heterotopic ossification (HO) that progressively affects skin, subcutaneous tissues, and deep skeletal muscle. PHP 1a is inherited maternally due to a GNAS mutation, while pure POH is inherited paternally. This case study presented a Chinese boy with congenital hypothyroidism, tonic-clonic seizures, hypoparathyroidism, AHO, POH, and joint fixation deformity. Sequencing analysis of GNAS-Gsα revealed a heterozygous C.432+2T>C(P.?) variant (NM_000516.7) affecting the canonical splice donor site of intron 5 in the boy and his mother, indicating maternal inheritance of a GNAS mutation. The patient was diagnosed with POH overlap syndrome (POH/PHP 1a). Following calcium and calcitriol supplementation, he experienced a reduction in seizures, and surgery was performed to correct the joint fixation deformity caused by HO. This case report provided valuable insights into the genotype-phenotype correlations of POH overlap syndrome and underscored the significance of genetic testing in diagnosing rare diseases.

biology
Long-term follow-up of a pseudohypoparathyroidism type 1A patient with missense mutation (Pro115Ser) in exon 5

Şenay Savaş Erdeve,Merih Berberoğlu,Zeynep Şıklar,Olcay Evliyaoğlu,Olaf Hiort,Gönül Öcal

DOI: https://doi.org/10.4274/jcrpe.v2i2.85

Abstract:Pseudohypoparathyroidism (PHP) refers to end-organ resistance that primarily impairs the renal actions of parathyroid hormone (PTH). The patients with PHP type Ia (PHP-Ia), one of the 4 types of PHP, show resistance to other peptide hormones as well as clinical features of Albright hereditary osteodystrophy (AHO), a constellation of short stature, obesity, brachydactyly, ectopic ossifications, and/or mental retardation. Here we report clinical follow-up for a long-term period in a PHP-Ia case who had a missense mutation leading to the substitution of proline by serine (Prol115Ser) in exon 5 which has been reported previously in only two patients. An 11-year-old boy applied for hand spasm to our hospital. On physical examination, he had short stature, round-shaped face and brachydactly. Laboratory evaluation revealed PTH and TSH resistance. Molecular genetic analysis of the GNAS gene revealed a P115S substitution. The patient was followed up for 13 years. Normocalcaemia was achieved with reduced doses of calcitriol (0.25 μg/day) and calcium supplements (40 mg/kg/day). Daily requirement for levothyroxine supplementation was still high (2.3 μg/kg) to achieve euthyroidism. His pubertal development was Tanner stage V and he has no gonadotropin resistance. To our knowledge, this is the first report concerning long-term follow-up of this rare mutation. We believe that despite the genetic heterogeneity of AHO, phenotype/genotype correlations of this kind of rare mutations may help to understand progress of the disease.
Case report: Familial hypoparathyroidism with elevated parathyroid hormone due to an inactivating PTH mutation

Noha Mukhtar,Balgees Alghamdi,Meshael Alswailem,Afaf Alsagheir,Ali S. Alzahrani

DOI: https://doi.org/10.3389/fendo.2024.1415639

IF: 6.055

2024-10-09

Frontiers in Endocrinology

Abstract:Introduction: So far, only 11 PTH mutations have been described as causes of familial isolated hypoparathyroidism (FIH). In this report, we describe a family with FIH but with significant elevation of functionally inactive PTH due to a PTH mutation. We also show a positive therapeutic outcome of recombinant human PTH (teriparatide) therapy in one of the siblings who was not well controlled on large doses of calcitriol and calcium replacement therapy. Case description: The proband is a 34-year-old woman who has a history of chronic severe hypocalcemia (HypoCa) since birth. She and her three brothers (33-year-old male twins, and a 21-year-old male) were diagnosed with pseudohypoparathyroidism type 1b (PHPT 1b) based on the presence of chronic HypoCa (serum Ca 1.6-1.85 mmol/l) since birth associated with significantly elevated plasma PTH levels in the range of 310-564 pg/dl (normal range 10-65) and absence of signs of Albright hereditary osteodystrophy. Molecular studies: WES showed no pathogenic, likely pathogenic or variants of unknown significance in any known calcium-associated genetic disorder but a bi-allelic variant in the PTH itself ((NM_000315.4:c.128G>A, p.Gly43Glu). This was confirmed by Sanger sequencing in the patient and her affected brothers. Management: Because the patient's HypoCa was not controlled on large doses of calcitriol and calcium carbonate, a trial of teriparatide 20 mcg SC daily was started and resulted in normalization of calcium, decline in PTH levels and significant improvement in her general wellbeing. Conclusion: High PTH in the presence of congenital hypocalcemia is not always due to receptor or post-receptor defect and can be due to a biologically inactive mutated PTH. In such cases, treatment with teriparatide may result in stabilization of biochemical profile and improvement in quality of life.

endocrinology & metabolism
Genetic Analysis of Pseudohypoparathyroidism Type Ⅰ a : Report of a Pedigree

ZHENG Rui-zhi,ZHAO Zhi-gang,WANG Yan-fang,YUAN Hui-juan,WANG Sui-jun,SU Yong,ZHANG Hui-feng,HU Zi-ying,MA Yue-hua,TIAN Rui,YUAN Qian,SHI Xiao-yang

DOI: https://doi.org/10.3760/cma.j.issn.1000-6699.2012.08.011

2012-01-01

Abstract:The clinical and genetic data were retrospectively analyzed in a pedigree with pseudohypoparathyroidism type Ⅰ a.Clinically typical Albright hereditary osteodystrophy (AHO),hypocalcemia,hyperphosphatemia,and PTH- and TSH-resistance were manifested in the proband,but not in his brother and parents.The proband's symptom of epilepsy was alleviated by treatment with calcium and vitamin D,which was of no avail in regard to AHO.After GNAS1 genes were sequenced and compared with the GenBank data among the family members,a deletion of c.1107_1108 ( p.Glu370ArgfsX11 ) in exon l3 of GNAS1 gene leading to a frameshift mutation was found in the proband and his mother.It suggested that the GNAS1 gene mutation might be related to the pathogenesis of the disease.
Case report of GNAS epigenetic defect revealed by a congenital hypothyroidism

Pauline Romanet,Lindsay Osei,Irène Netchine,Morgane Pertuit,Alain Enjalbert,Rachel Reynaud,Anne Barlier

DOI: https://doi.org/10.1542/peds.2014-2806

PEDIATRICS

Abstract:Pseudohypoparathyroidism (PHP) is a group of disorders characterized by end-organ resistance to the parathyroid hormone (PTH). PHP type 1A includes multihormone resistance syndrome, Albright's hereditary osteodystrophy, and obesity and is caused by mutations in GNAS exon 1 through 13. PHP type 1B (PHP1B), caused by epigenetic changes in the GNAS locus, was initially described as an isolated resistance to PTH. Epigenetic changes in GNAS have also been reported in patients who display mild Albright's hereditary osteodystrophy or mild thyroid-stimulating hormone (TSH) resistance without mutation of GNAS. Here we report a case of PHP caused by epigenetic changes in GNAS in a patient with congenital hypothyroidism. The patient was referred for a positive newborn screening for hypothyroidism (TSH 50 mIU/L). She exhibited severe clinical features of congenital hypothyroidism. The thyroid was in place, and etiologic explorations were negative. TSH was normalized under L-thyroxin, and the symptoms disappeared, except for a macroglossia. In childhood, PHP was suspected in addition to elevated PTH, obesity, brachydactyly, and a rounded face. Sequencing, methylation analysis, and large deletion research were performed in GNAS. No genetic mutations were found. Methylation analysis revealed a broad epigenetic defect without deletion in GNAS consistent with sporadic PHP1B. The multilocus methylation analysis were negative. This finding expands the known onsets of PHP1B and emphasizes the need for a new PHP classification system. This case report has important consequences for the etiologic diagnosis of congenital hypothyroidism because it adds a new cause of the disease.

[A disease accessible to treatment].

Preferential Maternal Transmission of STX16-GNAS Mutations Responsible for Autosomal Dominant Pseudohypoparathyroidism Type Ib (PHP1B): Another Example of Transmission Ratio Distortion

[Pseudohypoparathyroidism and GNAS Gene Defects: Clinical Evaluation and Molecular Analysis in 20 Children].

Lifelong Deformities in an Adult Caused by Vitamin D‑dependent Rickets Type 1A: A Case Report

STX16 exon 5–7 deletion in a patient with pseudohypoparathyroidism type 1B

Identification of a Novel Mutation in Pseudohypoparathyroidism Type Ia in a Chinese Family

The proximal-distal continuum of multiple health outcome measures: the case of cataract surgery.

WDM-PON Architecture with C-band OLT, L-band ONU, and U-band Monitoring Based on FP-LDs wavelength-locked by a Single, Depolarized, CW Supercontinuum

A diagnostic test for scrapie‐infected sheep using a capillary electrophoresis immunoassay with fluorescent‐labeled peptides

Diagnosis and approach of pseudohypoparathyroidism type 1A and related disorders during long term follow-up: a case report

Clinical and genetic analysis of pseudohypoparathyroidism complicated by hypokalemia: a case report and review of the literature

One Patient with Perinatal Hypophosphatasia Due to Mutations in the Tissue-Nonspecific Alkaline Phosphatase Gene

Clinical and Genetic Characteristics of Hypoparathyroidism in Children: a Multicenter Experience in China

Pseudohypoparathyroidism Type IB with Subclinical Hypothyroidism: a Pedigree Investigation and Literature Review

Growth Hormone Deficiency in an Adolescent With Pseudohypoparathyroidism Type 1B

High Prevalence of Hypercalcitoninemia in a Large Cohort of Adult and Pediatric Patients With PTH Resistance Syndromes

A novel GNAS mutation in pseudohypoparathyroidism type 1a with articular flexion deformity: A case report

Long-term follow-up of a pseudohypoparathyroidism type 1A patient with missense mutation (Pro115Ser) in exon 5

Case report: Familial hypoparathyroidism with elevated parathyroid hormone due to an inactivating PTH mutation

Genetic Analysis of Pseudohypoparathyroidism Type Ⅰ a : Report of a Pedigree

Case report of GNAS epigenetic defect revealed by a congenital hypothyroidism